Related references
Note: Only part of the references are listed.Encephalopathy with amyloid angiopathy and numerous amyloid plaques with low levels of CSF Aβ1-40/Aβ1-42
Masaki Ikeda et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2012)
Altered ?-secretase activity in mild cognitive impairment and Alzheimer's disease
Nobuto Kakuda et al.
EMBO MOLECULAR MEDICINE (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Cerebrospinal Fluid Tau, p-Tau 181 and Amyloid-beta(38/40/42) in Frontotemporal Dementias and Primary Progressive Aphasias
Mirko Bibl et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2011)
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies
Ezra Mulugeta et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Differential levels of α-synuclein, β-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
Kensaku Kasuga et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease
Erik Portelius et al.
MOLECULAR NEURODEGENERATION (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Longitudinal changes of CSF biomarkers in memory clinic patients
F. H. Bouwman et al.
NEUROLOGY (2007)
Does this patient have dementia?
Tracey Holsinger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
M Bibl et al.
BRAIN (2006)
A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease
A Ishikawa et al.
ANNALS OF NEUROLOGY (2005)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Highly conserved and disease-specific patterns of carboxyterminally truncated Aβ peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation
J Wiltfang et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Screening for PS1 mutations in a referral-based series of AD cases - 21 Novel mutations
EA Rogaeva et al.
NEUROLOGY (2001)
Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease
N Itoh et al.
ANNALS OF NEUROLOGY (2001)
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid:: a sandwich ELISA with a synthetic phosphopeptide for standardization
E Vanmechelen et al.
NEUROSCIENCE LETTERS (2000)
Share Paper
